Abstract
Non-coding RNA (ncRNA)-based therapeutics that induce RNA interference (RNAi), such as microRNAs (miRNAs), have drawn considerable attention as a novel class of targeted cancer therapeutics because of their capacity to specifically target oncogenes/protooncogenes that regulate key signaling pathways involved in carcinogenesis, tumor growth and progression, metastasis, cell survival, proliferation, angiogenesis, and drug resistance. However, clinical translation of miRNA-based therapeutics, in particular, has been challenging due to the ineffective delivery of ncRNA molecules into tumors and their uptake into cancer cells. Recently, superparamagnetic iron oxide-based nanoparticles (SPIONs) have emerged as highly effective and efficient for the delivery of therapeutic RNAs to malignant tissues, as well as theranostic (therapy and diagnostic) applications, due to their excellent biocompatibility, magnetic responsiveness, broad functional surface modification, safety, and biodistribution profiles. This review highlights recent advances in the use of SPIONs for the delivery of ncRNA-based therapeutics with an emphasis on their synthesis and coating strategies. Moreover, the advantages and current limitations of SPIONs and their future perspectives are discussed.
Graphical abstract
Similar content being viewed by others
Availability of data and materials
Not applicable.
References
M. Abu-Laban, R.R. Kumal, J. Casey, J. Becca, D. LaMaster, C.N. Pacheco, D.G. Sykes, L. Jensen, L.H. Haber, D.J. Hayes, Comparison of thermally actuated retro-diels-alder release groups for nanoparticle based nucleic acid delivery. J. Colloid Interface Sci. 526, 312–321 (2018)
D. Adams, A. Gonzalez-Duarte, W.D. O’Riordan, C.-C. Yang, M. Ueda, A.V. Kristen, I. Tournev, H.H. Schmidt, T. Coelho, J.L. Berk, Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379(1), 11–21 (2018)
T. Ahmad, H. Bae, I. Rhee, Y. Chang, J. Lee, S. Hong, Particle size dependence of relaxivity for silica-coated iron oxide nanoparticles. Curr. Appl. Phys. 12(3), 969–974 (2012)
T. Ahmadzada, G. Reid, D.R. McKenzie, Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophys. Rev. 10, 69–86 (2018)
N. Ajinkya, X. Yu, P. Kaithal, H. Luo, P. Somani, S. Ramakrishna, Magnetic iron oxide nanoparticle (IONP) synthesis to applications: present and future. Materials 13(20), 4644 (2020)
H. Akbaba, U. Karagöz, Y. Selamet, A.G. Kantarcı, Synthesis and characterization of cationic lipid coated magnetic nanoparticles using multiple emulsions as microreactors. J. Magn. Magn. Mater. 426, 518–524 (2017)
A. Ali, H. Zafar, M. Zia, I. ul Haq, A.R. Phull, J.S. Ali, A. Hussain, Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol. Sci. App. 49–67 (2016)
E. Alphandéry, Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease. Nanotoxicology 13(5), 573–596 (2019)
E. Alphandéry, Iron oxide nanoparticles for therapeutic applications. Drug Discov. Today 25(1), 141–149 (2020)
U. Anand, A. Dey, A.K.S. Chandel, R. Sanyal, A. Mishra, D.K. Pandey, V. De Falco, A. Upadhyay, R. Kandimalla, A. Chaudhary, J.K. Dhanjal, Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. (2022)
J.H. Arrizabalaga, J.S. Casey, J.C. Becca, Y. Liu, L. Jensen, D.J. Hayes, Development of magnetic nanoparticles for the intracellular delivery of miR-148b in non-small cell lung cancer. Biomed. Eng. Adv. 3, 100031 (2022)
A. Avasthi, C. Caro, E. Pozo‑Torres, M.P. Leal, M.L. García‑Martín, Magnetic nanoparticles as MRI contrast agents. Surface-modified Nanobiomater. Electrochem. Biomed. App. l49–91 (2020)
K.S. Bhullar, N.O. Lagarón, E.M. McGowan, I. Parmar, A. Jha, B.P. Hubbard, H.V. Rupasinghe, Kinase-targeted cancer therapies: progress, challenges and future directions. Mol. Cancer 17, 1–20 (2018)
P.-O. Champagne, H. Westwick, A. Bouthillier, M. Sawan, Colloidal stability of superparamagnetic iron oxide nanoparticles in the central nervous system: a review. Nanomedicine 13(11), 1385–1400 (2018)
T. Chan, F. Gu, Development of a colorimetric, superparamagnetic biosensor for the capture and detection of biomolecules. Biosens. Bioelectron. 42, 12–16 (2013)
X. Chen, L.S. Mangala, C. Rodriguez-Aguayo, X. Kong, G. Lopez-Berestein, A.K. Sood, RNA interference-based therapy and its delivery systems. Cancer Metastasis Rev. 37, 107–124 (2018)
K. Chen, J. Xie, H. Xu, D. Behera, M.H. Michalski, S. Biswal, A. Wang, X. Chen, Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials. 30(36), 6912–6919 (2009)
T. Cristofolini, M. Dalmina, J.A. Sierra, A.H. Silva, A.A. Pasa, F. Pittella, T.B. Creczynski-Pasa, Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells. Mater. Sci. Eng. C 109(2020)
S.M. Dadfar, K. Roemhild, N.I. Drude, S. von Stillfried, R. Knüchel, F. Kiessling, T. Lammers, Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv. Drug Deliv. Rev. 138, 302–325 (2019)
F. Danhier, To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? J. Control. Release 244, 108–121 (2016)
I. Dasgupta, A. Chatterjee, Recent advances in miRNA delivery systems. Methods Protoc. 4(1), 10 (2021)
V. De Matteis, Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluation. Toxics 5(4), 29 (2017)
E.B. Denkbaş, E. Celik, E. Erdal, D. Kavaz, Ö. Akbal, G. Kara, C. Bayram Magnetically based nanocarriers in drug delivery. Nanobiomater. Drug Deliv. Elsevier 285–331 (2016)
A. Dirisala, S. Uchida, K. Toh, J. Li, S. Osawa, T.A. Tockary, X. Liu, S. Abbasi, K. Hayashi, Y. Mochida, Transient stealth coating of liver sinusoidal wall by anchoring two-armed PEG for retargeting nanomedicines. Sci. Adv. 6(26), eabb8133 (2020)
P. Dong, T. Zhang, H. Xiang, X. Xu, Y. Lv, Y. Wang, C. Lu, Controllable synthesis of exceptionally small-sized superparamagnetic magnetite nanoparticles for ultrasensitive MR imaging and angiography. J. Mater. Chem. B 9(4), 958–968 (2021)
J. Dulińska-Litewka, A. Łazarczyk, P. Hałubiec, O. Szafrański, K. Karnas, A. Karewicz, Superparamagnetic iron oxide nanoparticles—Current and prospective medical applications. Materials 12(4), 617 (2019)
S. El Sayed, J. Cristante, L. Guyon, J. Denis, O. Chabre, N. Cherradi, MicroRNA therapeutics in cancer: current advances and challenges. Cancers 13, 2680 (2021)
R.P. Friedrich, I. Cicha, C. Alexiou, Iron oxide nanoparticles in regenerative medicine and tissue engineering. Nanomaterials 11(9), 2337 (2021)
L.S. Ganapathe, M.A. Mohamed, R. Mohamad Yunus, D.D. Berhanuddin, Magnetite (Fe3O4) nanoparticles in biomedical application: From synthesis to surface functionalisation. Magnetochemistry 6(4), 68 (2020)
A. Ganju, S. Khan, B.B. Hafeez, S.W. Behrman, M.M. Yallapu, S.C. Chauhan, M. Jaggi, miRNA nanotherapeutics for cancer. Drug Discov Today 22(2), 424–432 (2017)
Y. Gao, H. Qian, X. Tang, X. Du, G. Wang, H. Zhang, F. Ye, T. Liu, Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth. Int. J. Nanomed. 2719–2731 (2019)
S. Guo, L. Huang, Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy. J Nanomater 1–12 (2011)
M. Gong, H. Liu, N. Sun, Y. Xie, F. Yan, L. Cai, Polyethylenimine-dextran-coated magnetic nanoparticles loaded with miR-302b suppress osteosarcoma in vitro and in vivo. Nanomedicine 15(07), 711–723 (2020)
A.K. Gupta, M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterial 26(18), 3995–4021 (2005)
H. Hosseinkazemi, S. Samani, A. O’Neill, M. Soezi, M. Moghoofei, M.H. Azhdari, F. Aavani, A. Nazbar, S.H. Keshel, M. Doroudian, Applications of iron oxide nanoparticles against breast cancer. J. Nanomater. 2022, 1–12 (2022)
S.H. Hu, T.Y. Hsieh, C.S. Chiang, P.J. Chen, Y.Y. Chen, T.L. Chiu, S.Y. Chen, Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery. Adv. Healthcare Mater. 3(2), 273–282 (2014)
S.R. Iyer, S. Xu, J.P. Stains, C.H. Bennett, R.M. Lovering, Superparamagnetic iron oxide nanoparticles in musculoskeletal biology. Tissue Eng. Part B: Rev. 23(4), 373–385 (2017)
L. Jin, Q. Wang, J. Chen, Z. Wang, H. Xin, D. Zhang, Efficient delivery of therapeutic siRNA by Fe3O4 magnetic nanoparticles into oral cancer cells. Pharmaceutics 11(11), 615 (2019)
A. Joseph, S. Mathew, Ferrofluids: synthetic strategies, stabilization, physicochemical features, characterization, and applications. ChemPlusChem 79(10), 1382–1420 (2014)
G. Kandasamy, D. Maity, Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. Int. J. Pharm. 496(2), 191–218 (2015)
M.A. Kang, J. Fang, A. Paragodaarachchi, K. Kodama, D. Yakobashvili, Y. Ichiyanagi, H. Matsui, Magnetically induced brownian motion of iron oxide nanocages in alternating magnetic fields and their application for efficient SiRNA delivery. Nano Lett. 22(22), 8852–8859 (2022)
G. Kara, B. Arun, G.A. Calin, B. Ozpolat, miRacle of microRNA-driven cancer nanotherapeutics. Cancers 14(15), 3818 (2022a)
G. Kara, G.A. Calin, B. Ozpolat, RNAi-based therapeutics and tumor targeted delivery in cancer. Adv. Drug Deliv. Rev. 182 (2022b)
G. Kara, S. Malekghasemi, B. Ozpolat, E.B. Denkbas, Development of novel poly-l-lysine-modified sericin-coated superparamagnetic iron oxide nanoparticles as siRNA carrier. Colloids Surf. A 630 (2021)
G. Kara, B. Ozpolat, In vivo miR-449b mimic-based nanotherapy suppresses growth and progression of triple-negative breast cancer. Cancer Res. 83(7_Supplement), 3786–3786 (2023)
F.M. Kievit, M. Zhang, Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc. Chem. Res. 44(10), 853–862 (2011)
S.J. Kim, B. Lewis, M.S. Steiner, U.V. Bissa, C. Dose, J.A. Frank, Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking. Contrast Media Mol. Imaging 11(1), 55–64 (2016)
K.M. Krishnan, Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans. Magn. 46(7), 2523–2558 (2010)
P. Krzyszczyk, A. Acevedo, E.J. Davidoff, L.M. Timmins, I. Marrero-Berrios, M. Patel, C. White, C. Lowe, J.J. Sherba, C. Hartmanshenn, The growing role of precision and personalized medicine for cancer treatment. Technology 6(03n04), 79–100 (2018)
M. Kubovcikova, M. Koneracka, O. Strbak, M. Molcan, V. Zavisova, I. Antal, I. Khmara, D. Lucanska, L. Tomco, M. Barathova, Poly-L-lysine designed magnetic nanoparticles for combined hyperthermia, magnetic resonance imaging and cancer cell detection. J. Magn. Magn. Mater. 475, 316–326 (2019)
J.K. Lam, M.Y. Chow, Y. Zhang, S.W. Leung, siRNA versus miRNA as therapeutics for gene silencing. Molecular Therapy-Nucleic Acids 4 (2015)
N. Lamichhane, M.E. Sharifabad, B. Hodgson, T. Mercer, T. Sen, Superparamagnetic iron oxide nanoparticles (SPIONs) as therapeutic and diagnostic agents (Elsevier, Nanoparticle therapeutics, 2022), pp.455–497
S. Laurent, A.A. Saei, S. Behzadi, A. Panahifar, M. Mahmoudi, Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges. Expert Opin. Drug Deliv. 11(9), 1449–1470 (2014)
K. Li, H. Nejadnik, H.E. Daldrup-Link, Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics. Drug Discovery Today 22(9), 1421–1429 (2017)
L. Li, L.-L. Jiang, Y. Zeng, G. Liu, Toxicity of superparamagnetic iron oxide nanoparticles: research strategies and implications for nanomedicine. Chin. Phys. B 22(12)(2013)
L. Li, W. Jiang, K. Luo, H. Song, F. Lan, Y. Wu, Z. Gu, Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics 3(8), 595 (2013)
C. Liang, X. Zhang, Z. Cheng, M. Yang, W. Huang, X. Dong, Magnetic iron oxide nanomaterials: a key player in cancer nanomedicine. View 1(3), 20200046 (2020)
V. Llombart, M.R. Mansour, Therapeutic targeting of “undruggable” MYC. EBioMedicine 75 (2022)
Y.-L. Lo, H.-L. Chou, Z.-X. Liao, S.-J. Huang, J.-H. Ke, Y.-S. Liu, C.-C. Chiu, L.-F. Wang, Chondroitin sulfate-polyethylenimine copolymer-coated superparamagnetic iron oxide nanoparticles as an efficient magneto-gene carrier for microRNA-encoding plasmid DNA delivery. Nanoscale 7(18), 8554–8565 (2015)
X.J. Loh, T.-C. Lee, Q. Dou, G.R. Deen, Utilising inorganic nanocarriers for gene delivery. Biomater. Sci. 4(1), 70–86 (2016)
C.-H. Lu, J.-K. Hsiao, Diagnostic and therapeutic roles of iron oxide nanoparticles in biomedicine. Tzu-Chi Med. J. 35(1), 11 (2023)
D. Lu, X. Wu, W. Wang, C. Ma, B. Pei, S. Wu, Synthesis and application of Iron Oxide nanoparticles in bone tissue repair. J. Nanomater. 2021, 1–14 (2021)
U.M. Mahajan, S. Teller, M. Sendler, R. Palankar, C. van den Brandt, T. Schwaiger, J.-P. Kühn, S. Ribback, G. Glöckl, M. Evert, Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer. Gut 65(11), 1838–1849 (2016)
M. Mahmoudi, S. Sant, B. Wang, S. Laurent, T. Sen, Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 63(1–2), 24–46 (2011)
H. Majeed, V. Gupta, Adverse effects of radiation therapy. (2020)
S. Majidi, F. Zeinali Sehrig, S.M. Farkhani, M. Soleymani Goloujeh, A. Akbarzadeh, Current methods for synthesis of magnetic nanoparticles. Artif. Cells Nanomed. Biotechnol. 44(2), 722–734 (2016)
L. Maldonado-Camargo, M. Unni, C. Rinaldi, Magnetic characterization of iron oxide nanoparticles for biomedical applications. Biomed. Nanotechnol. Methods Protocols 47–71 (2017)
N. Malhotra, J.-S. Lee, R.A.D. Liman, J.M.S. Ruallo, O.B. Villaflores, T.-R. Ger, C.-D. Hsiao, Potential toxicity of iron oxide magnetic nanoparticles: a review. Molecules 25(14), 3159 (2020)
M.T. Manzari, Y. Shamay, H. Kiguchi, N. Rosen, M. Scaltriti, D.A. Heller, Targeted drug delivery strategies for precision medicines. Nat. Rev. Mater. 6(4), 351–370 (2021)
C. Mattiuzzi, G. Lippi, Current cancer epidemiology. J. Epidemiol. Global Health 9(4), 217 (2019)
I. Merinopoulos, T. Gunawardena, C. Stirrat, D. Cameron, S.C. Eccleshall, M.R. Dweck, D.E. Newby, V.S. Vassiliou, Diagnostic applications of ultrasmall superparamagnetic particles of iron oxide for imaging myocardial and vascular inflammation. Cardiovascular Imag. 14(6), 1249–1264 (2021)
A. Mittal, I. Roy, S. Gandhi, Magnetic nanoparticles: An overview for biomedical applications. Magnetochemistry 8(9), 107 (2022)
H. Mok, M. Zhang, Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin. Drug Deliv. 10(1), 73–87 (2013)
M.Y. Momin, R.R. Gaddam, M. Kravitz, A. Gupta, A. Vikram, The challenges and opportunities in the development of MicroRNA therapeutics: a multidisciplinary viewpoint. Cells 10(11), 3097 (2021)
M.G. Montiel Schneider, M.J. Martín, J. Otarola, E. Vakarelska, V. Simeonov, V. Lassalle, M. Nedyalkova, Biomedical applications of iron oxide nanoparticles: Current insights progress and perspectives. Pharmaceutics 14(1), 204 (2022)
V. Mulens-Arias, J.M. Rojas, S. Pérez-Yagüe, M.P. Morales, D.F. Barber, Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics. Biomaterials 52, 494–506 (2015)
M. Muthiah, I.-K. Park, C.-S. Cho, Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol. Adv. 31(8), 1224–1236 (2013)
H.B. Na, I.C. Song, T. Hyeon, Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 21(21), 2133–2148 (2009)
P. Navya, A. Kaphle, S. Srinivas, S.K. Bhargava, V.M. Rotello, H.K. Daima, Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano convergence 6(1), 1–30 (2019)
M.D. Nguyen, H.-V. Tran, S. Xu, T.R. Lee, Fe3O4 Nanoparticles: Structures, synthesis, magnetic properties, surface functionalization, and emerging applications. Appl. Sci. 11(23), 11301 (2021)
O.A. Noqta, A.A. Aziz, I.A. Usman, M. Bououdina, Recent advances in iron oxide nanoparticles (IONPs): synthesis and surface modification for biomedical applications. J. Supercond. Novel Magn. 32, 779–795 (2019)
B. Ouyang, W. Poon, Y.-N. Zhang, Z.P. Lin, B.R. Kingston, A.J. Tavares, Y. Zhang, J. Chen, M.S. Valic, A.M. Syed, The dose threshold for nanoparticle tumour delivery. Nat. Mater. 19(12), 1362–1371 (2020)
S. Palanisamy, Y.-M. Wang, Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer. Dalton Trans. 48(26), 9490–9515 (2019)
Z. Pan, Y. Huang, H. Qian, X. Du, W. Qin, T. Liu, Superparamagnetic iron oxide nanoparticles drive miR-485-5p inhibition in glioma stem cells by silencing Tie1 expression. Int. J. Biol. Sci. 16(7), 1274 (2020)
J. Park, J. Park, Y. Pei, J. Xu, Y. Yeo, Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Adv. Drug Deliv. Rev. 104, 93–109 (2016)
K. Paunovska, D. Loughrey, J.E. Dahlman, Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23(5), 265–280 (2022)
A.K. Pearce, R.K. O’Reilly, Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine. Bioconjug. Chem. 30(9), 2300–2311 (2019)
P. Pedrosa, R. Vinhas, A. Fernandes, P.V. Baptista, Gold nanotheranostics: proof-of-concept or clinical tool? Nanomaterials 5(4), 1853–1879 (2015)
Y. Peng, Y. Gao, C. Yang, R. Guo, X. Shi, X. Cao, Low-molecular-weight poly (ethylenimine) nanogels loaded with ultrasmall iron oxide nanoparticles for T 1-weighted MR imaging-guided gene therapy of sarcoma. ACS Appl. Mater. Interfaces 13(24), 27806–27813 (2021)
M. Perepelyuk, C. Thangavel, Y. Liu, R.B. Den, B. Lu, A.E. Snook, S.A. Shoyele, Biodistribution and pharmacokinetics study of siRNA-loaded anti-NTSR1-mAb-functionalized novel hybrid nanoparticles in a metastatic orthotopic murine lung cancer model. Mol Therapy-Nucleic Acids 5 (2016)
S. Prijic, G. Sersa, Magnetic nanoparticles as targeted delivery systems in oncology. Radiol. Oncol. 45(1), 1–16 (2011)
C. Pucci, A. Degl’Innocenti, M.B. Gümüş, G. Ciofani, Superparamagnetic iron oxide nanoparticles for magnetic hyperthermia: Recent advancements, molecular effects, and future directions in the omics era. Biomater. Sci. 10(9), 2103–2121 (2022)
M. Rahman, Magnetic Resonance Imaging and Iron-oxide Nanoparticles in the era of Personalized Medicine. Nanotheranostics 7(4), 424 (2023)
H. Raskov, A. Orhan, S. Gaggar, I. Gögenur, Cancer-associated fibroblasts and tumor-associated macrophages in cancer and cancer immunotherapy. Front. Oncol. 11(2021)
R.A. Revia, Z.R. Stephen, M. Zhang, Theranostic nanoparticles for RNA-based cancer treatment. Acc. Chem. Res. 52(6), 1496–1506 (2019)
J.J. Rychak, A.L. Klibanov, Nucleic acid delivery with microbubbles and ultrasound. Adv. Drug Deliv. Rev. 72, 82–93 (2014)
V. Sachdeva, A. Monga, R. Vashisht, D. Singh, A. Singh, N. Bedi, Iron Oxide Nanoparticles: The precise strategy for targeted delivery of genes, oligonucleotides and peptides in cancer therapy. J. Drug Deliv. Sci. Technol. 103585 (2022)
A.V. Samrot, C.S. Sahithya, J. Selvarani, S.K. Purayil, P. Ponnaiah, A review on synthesis, characterization and potential biological applications of superparamagnetic iron oxide nanoparticles. Current Research in Green and Sustainable Chemistry 4(2021)
M. Segal, F.J. Slack, Challenges identifying efficacious miRNA therapeutics for cancer. Expert Opin. Drug Discov. 15(9), 987–991 (2020)
A. Selimovic, G. Kara, E.B. Denkbas, Magnetic gelatin nanoparticles as a biocompatible carrier system for small interfering RNA in human colorectal cancer: Synthesis, optimization, characterization, and cell viability studies. Mater. Today Commun. 33, 104616 (2022)
D.Y. Seo, M. Jin, J.-C. Ryu, Y.-J. Kim, Investigation of the genetic toxicity by dextran-coated superparamagnetic iron oxide nanoparticles (SPION) in HepG2 cells using the comet assay and cytokinesis-block micronucleus assay. Toxicol. Environ. Heal. Sci. 9, 23–29 (2017)
S. Setua, M. Jaggi, M. M. Yallapu, S. C. Chauhan, A. Danilushkina, H. Lee, I. S. Choi, R. Fakhrullin, L. Degli Esposti, A. Tampieri, Targeted and theranostic applications for nanotechnologies in medicine. Nanotechnol. Prevent Regenerative Med. Elsevier 399–511 (2018)
A.M.E. Shafey, Green synthesis of metal and metal oxide nanoparticles from plant leaf extracts and their applications: A review. Green Process Synth. 9(1), 304–339 (2020)
M.B. Shete, T.S. Patil, A.S. Deshpande, G. Saraogi, N. Vasdev, M. Deshpande, K. Rajpoot, R.K. Tekade, Current trends in theranostic nanomedicines. J Drug Deliv Sci Technol 71, 103280 (2022)
H. Shin, S.J. Park, Y. Yim, J. Kim, C. Choi, C. Won, D.H. Min, Recent advances in RNA therapeutics and RNA delivery systems based on nanoparticles. Advanced Therapeutics 1(7), 1800065 (2018)
A. Shirangi, F. Mottaghitalab, S. Dinarvand, F. Atyabi, Theranostic silk sericin/SPION nanoparticles for targeted delivery of ROR1 siRNA: Synthesis, characterization, diagnosis and anticancer effect on triple-negative breast cancer. Int. J. Biol. Macromol. 221, 604–612 (2022)
S.A. Smith, L.I. Selby, A.P. Johnston, G.K. Such, The endosomal escape of nanoparticles: toward more efficient cellular delivery. Bioconjug. Chem. 30(2), 263–272 (2018)
B.K. Sodipo, A.A. Aziz, Recent advances in synthesis and surface modification of superparamagnetic iron oxide nanoparticles with silica. J. Magn. Magn. Mater. 416, 275–291 (2016)
I. Soerjomataram, F. Bray, Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat. Rev. Clin. Oncol. 18(10), 663–672 (2021)
Z. Sohrabijam, M. Saeidifar, A. Zamanian, Enhancement of magnetofection efficiency using chitosan coated superparamagnetic iron oxide nanoparticles and calf thymus DNA. Colloids Surf., B 152, 169–175 (2017)
C. Strehl, L. Maurizi, T. Gaber, P. Hoff, T. Broschard, A. R. Poole, H. Hofmann, F. Buttgereit, Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans. Int. J. Nanomed. 5883–5896 (2016)
M. Suciu, C.M. Ionescu, A. Ciorita, S.C. Tripon, D. Nica, H. Al-Salami, L. Barbu-Tudoran, Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements. Beilstein J. Nanotechnol. 11(1), 1092–1109 (2020)
U.K. Sukumar, R.J. Bose, M. Malhotra, H.A. Babikir, R. Afjei, E. Robinson, Y. Zeng, E. Chang, F. Habte, R. Sinclair, Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide. Biomaterials 218(2019)
Z. Sun, X. Song, X. Li, T. Su, S. Qi, R. Qiao, F. Wang, Y. Huan, W. Yang, J. Wang, In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model. Nanoscale 6(23), 14343–14353 (2014)
Y.K. Sung, S. Kim, Recent advances in the development of gene delivery systems. Biomaterials research 23, 1–7 (2019)
G.M. Traber, A.-M. Yu, RNAi-based therapeutics and novel RNA bioengineering Technologies. J. Pharmacol. Exp. Ther. 384(1), 133–154 (2023)
N. Usov, Iron oxide nanoparticles for magnetic hyperthermia (World Scientific, Spin, 2019)
C. Vasilescu, M. Latikka, K.D. Knudsen, V.M. Garamus, V. Socoliuc, R. Turcu, E. Tombácz, D. Susan-Resiga, R. Ras, L. Vékás, High concentration aqueous magnetic fluids: structure, colloidal stability, magnetic and flow properties. Soft Matter 14(32), 6648–6666 (2018)
O. Veiseh, J.W. Gunn, M. Zhang, Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62(3), 284–304 (2010)
N. Wahajuddin, S. Arora, Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int. J. Nanomed. 3445–3471 (2012)
Y. Wang, Z. Huang, C.Z. Chen, C. Liu, C.P. Evans, A.C. Gao, F. Zhou, H.-W. Chen, Therapeutic targeting of MDR1 expression by RORγ antagonists resensitizes cross-resistant CRPC to taxane via coordinated induction of cell death programs. Mol. Cancer Ther. 19(2), 364–374 (2020)
S. Wilhelm, A.J. Tavares, Q. Dai, S. Ohta, J. Audet, H.F. Dvorak, W.C. Chan, Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1(5), 1–12 (2016)
T. Wirth, S. Ylä-Herttuala, Gene therapy used in cancer treatment. Biomedicines 2(2), 149–162 (2014)
W. Wu, Z. Wu, T. Yu, C. Jiang, W.-S. Kim, Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci. Technol. Adv. Mater. 16(2)(2015)
X. Xiang, J. Wang, D. Lu, X. Xu, Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct. Target. Ther. 6(1), 75 (2021)
Y. Xiao, J. Du, Superparamagnetic nanoparticles for biomedical applications. J. Mater. Chem. B 8(3), 354–367 (2020)
J. Xie, S. Lee, X. Chen, Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev. 62(11), 1064–1079 (2010)
Y. Yan, X.-Y. Liu, A. Lu, X.-Y. Wang, L.-X. Jiang, J.-C. Wang, Non-viral vectors for RNA delivery. J. Control. Release 342, 241–279 (2022)
Z. Yang, J. Duan, J. Wang, Q. Liu, R. Shang, X. Yang, P. Lu, C. Xia, L. Wang, K. Dou, Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy. Int. J. Nanomed. 1851–1865 (2018)
Y. Yao, Y. Zhou, L. Liu, Y. Xu, Q. Chen, Y. Wang, S. Wu, Y. Deng, J. Zhang, A. Shao, Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front. Mol. Biosci. 7, 193 (2020)
H. Yin, R.L. Kanasty, A.A. Eltoukhy, A.J. Vegas, J.R. Dorkin, D.G. Anderson, Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 15(8), 541–555 (2014)
M. Yu, S. Huang, K.J. Yu, A.M. Clyne, Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 13(5), 5554–5570 (2012)
Y. Yu, D. Sun, Superparamagnetic iron oxide nanoparticle ‘theranostics’ for multimodality tumor imaging, gene delivery, targeted drug and prodrug delivery. Expert. Rev. Clin. Pharmacol. 3(1), 117–130 (2010)
A. Zarepour, A. Zarrabi, A. Khosravi, A. Zarepour, A. Zarrabi, A. Khosravi, Spions as nano-theranostics agents (Springer, 2017)
J. Zhang, T. Zhang, J. Gao, Biocompatible iron oxide nanoparticles for targeted cancer gene therapy: A review. Nanomaterials 12(19), 3323 (2022)
Y. Zhang, X. Fu, J. Jia, T. Wikerholmen, K. Xi, Y. Kong, J. Wang, H. Chen, Y. Ma, Z. Li, Glioblastoma therapy using codelivery of cisplatin and glutathione peroxidase targeting siRNA from iron oxide nanoparticles. ACS Appl. Mater. Interf. 12(39), 43408–43421 (2020)
S. Zhao, X. Yu, Y. Qian, W. Chen, J. Shen, Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics. Theranostics 10(14), 6278 (2020)
Z. Zhao, M. Li, J. Zeng, L. Huo, K. Liu, R. Wei, K. Ni, J. Gao, Recent advances in engineering iron oxide nanoparticles for effective magnetic resonance imaging. Bioactive Mater. 12, 214–245 (2022)
M. Zheng, D. Librizzi, A. Kılıç, Y. Liu, H. Renz, O.M. Merkel, T. Kissel, Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly (ethylene glycol) copolymers. Biomaterials 33(27), 6551–6558 (2012)
C. Zhu, X. Guan, X. Zhang, X. Luan, Z. Song, X. Cheng, W. Zhang, J.-J. Qin, Targeting KRAS mutant cancers: from druggable therapy to drug resistance. Mol. Cancer 21(1), 159 (2022)
L. Zhu, Z. Zhou, H. Mao, L. Yang, Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy. Nanomedicine 12(1), 73–87 (2017)
Funding
None.
Author information
Authors and Affiliations
Contributions
G.K. investigation, writing original draft B.O. Writing – review & editing.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kara, G., Ozpolat, B. SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer. Biomed Microdevices 26, 16 (2024). https://doi.org/10.1007/s10544-024-00698-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s10544-024-00698-y